Preparation, characterization and evaluation of solid lipid nanoparticles and niosomes for ING4 gene delivery to MCF-7 cells

Year 2019, Volume: 23 Issue: 5, 935 - 943, 27.06.2025

Uğur Karagöz Ayşe Gülten Kantarci

Abstract

In this study, we aimed to develop lipid-based delivery systems for ING4 gene. For this purpose, we chose solid lipid nanoparticle (SLN) and niosome formulations for their advantages in several ways. SLNs were prepared via hot microemulsion method with slight modifications. Niosomes were prepared by using thin film hydration method. Both of those formulations contain cationic lipids for the purpose of gaining positive charge. Thus, complexation with ING4 gene carrier plasmid DNA is conducted via electrostatic interactions. DLS measurements showed us both of those formulations have appropriate zeta potential for complexation which is above 30 mV. Average particle size of SLNs is 9.76±0.13 nm. Vesicle size of niosomes is 483.2 ± 20.19 nm. Both of those formulations can be considered nano-sized delivery systems. Reliability of those values were supported with TEM imaging. DNA protection ability of those formulations were observed in serum stability study. After characterization studies, cytotoxic effect of those delivery systems was evaluated on MCF-7 cell lines.

Keywords

ING4 , solid lipid nanoparticles , niosomes , gene delivery

References

• [1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. Ca-Cancer J Clin. 2019; 69(1): 7-34. [CrossRef]
• [2] Chang L, Weiner LS, Hartman SJ, Horvath S, Jeste D, Mischel PS, Kado DM. Breast cancer treatment and its effects on aging. J Geriatr Oncol. 2019; 10(2): 346–355. [CrossRef]
• [3] Ju J, Zhu A-J, Yuan P. Progress in targeted therapy for breast cancer. Chronic Dis Transl Med. 2018; 4(3): 164–175. [CrossRef]
• [4] Wei Q, He W, Lu Y, Yao J, Cao X. Effect of the tumor suppressor gene ING4 on the proliferation of MCF-7 human breast cancer cells. Oncol Lett. 2012; 1(10): 438–442. [CrossRef]
• [5] Pan X, Wang R, Bian H, De W, Zhang P, Wei C, Wang Z. Overexpression of inhibitor of growth 4 enhances radiosensitivity in non-small cell lung cancer cell line SPC-A1. Technol Cancer Res Treat. 2017; 16(5): 533–545. [CrossRef]
• [6] Shao B, Liu E. Expression of ing4 is negatively correlated with cellular proliferation and microvessel density in human glioma. Oncol Lett. 2017; 14(3): 3663–3668. [CrossRef]
• [7] Cui S, Gao Y, Zhang K, Chen J, Wang R, Chen L. The emerging role of inhibitor of growth 4 as a tumor suppressor in multiple human cancers. Cell Physiol Biochem. 2015; 36(2): 409–422. [CrossRef]
• [8] Solinís MÁ, Del Pozo-Rodríguez A, Apaolaza PS, Rodríguez-Gascón A. Treatment of ocular disorders by gene therapy. Eur J Pharm Biopharm. 2015; 95: 331–342. [CrossRef]
• [9] Madkhali O, Mekhail G, Wettig SD. Modified gelatin nanoparticles for gene delivery. Int J Pharm. 2019; 554: 224–234. [CrossRef]
• [10] Trucillo P, Campardelli R. Production of solid lipid nanoparticles with a supercritical fluid assisted process. J Supercrit Fluid. 2019; 143: 16–23. [CrossRef]
• [11] Dara T, Vatanara A, Meybodi MN, Vakilinezhad MA, Malvajerd SS, Vakhshiteh F, Shamsian A, Sharifzadeh M, Kaghazian H, Mosaddegh MH. Erythropoietin-loaded solid lipid nanoparticles: Preparation, optimization, and in vivo evaluation. Colloids Surf B. 2019; 178: 307–316. [CrossRef]
• [12] Fàbregas A, Sánchez-Hernández N, Ticó JR, García-Montoya E, Pérez-Lozano P, Suñé-Negre JM, Hernández-Munain C, Suñé C, Miñarro M. A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: Development, characterization and DNA binding efficiency of TCERG1 expression plasmid. Int J Pharm. 2014; 473(1–2): 270–279. [CrossRef]
• [13] Carrillo C, Sánchez-Hernández N, García-Montoya E, Pérez-Lozano P, Suñé-Negre JM, Ticó JR, Suñé C, Miñarro M. DNA delivery via cationic solid lipid nanoparticles (SLNs). Eur J Pharm Sci. 2013; 49(2): 157–165. [CrossRef]
• [14] Ojeda E, Puras G, Agirre M, Zarate J, Grijalvo S, Eritja R, Digiacomo L, Caracciolo G, Pedraz JL. The role of helper lipids in the intracellular disposition and transfection efficiency of niosome formulations for gene delivery to retinal pigment epithelial cells. Int J Pharm. 2016; 503(1–2): 115–126. [CrossRef]
• [15] Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: An illustrated review. J Control Release. 2014; 185(1): 22–36. [CrossRef]
• [16] Yadav N, Kumar N, Prasad P, Shirbhate S, Sehrawat S, Lochab B. Stable Dispersions of Covalently Tethered Polymer Improved Graphene Oxide Nanoconjugates as an Effective Vector for siRNA Delivery. ACS Appl Mater Interfaces. 2018; 10(17): 14577–14593. [CrossRef]
• [17] Sheikhsaran F, Sadeghpour H, Khalvati B, Entezar-Almahdi E, Dehshahri A. Tetraiodothyroacetic acid-conjugated polyethylenimine for integrin receptor mediated delivery of the plasmid encoding IL-12 gene. Colloids Surf B. 2017; 150: 426–436. [CrossRef]
• [18] Xu F, Rychnovsky SD, Belani JD, Hobbs HH, Cohen JC, Rawson RB. Dual roles for cholesterol in mammalian cells. Proc Natl Acad Sci USA. 2005; 102(41): 14551–14556. [CrossRef]
• [19] Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine. 2012; 7: 5577–5591. [CrossRef]
• [20] Kotmakçı M, Akbaba H, Erel G, Ertan G, Kantarcı G. Improved method for solid lipid nanoparticle preparation based on hot microemulsions: Preparation, characterization, cytotoxicity, and hemocompatibility evaluation. AAPS Pharm Sci Tech. 2017; 18(4): 1355–1365. [CrossRef]
• [21] Pando D, Matos M, Gutiérrez G, Pazos C. Formulation of resveratrol entrapped niosomes for topical use. Colloids Surf B. 2015; 128: 398–404. [CrossRef]
• [22] Abdelbary AA, Aboughaly MHH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015; 485(1–2): 235–243. [CrossRef]
• [23] Han H, Chen W, Yang J, Liang X, Wang Y, Li Q, Yang Y, Li K. Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery. Int J Nanomedicine. 2018; 13: 1297–1311. [CrossRef]
• [24] Peng SF, Hsu HK, Lin CC, Cheng YM, Hsu KH. Novel PEI/Poly-γ-Gutamic Acid Nanoparticles for High Efficient siRNA and Plasmid DNA Co-Delivery. Molecules. 2017; 22–86. [CrossRef]